Anthony Moffa
About Anthony Moffa
Anthony Moffa is the Lead Process Engineer I at Alkermes, with extensive experience in process development and technical operations within the pharmaceutical industry.
Current Role at Alkermes
Anthony Moffa currently holds the title of Lead Process Engineer I at Alkermes. In his role, he is responsible for overseeing process engineering projects and ensuring the efficiency and efficacy of pharmaceutical production processes. His position is remote, allowing for flexible collaboration with cross-functional teams and departments within the company.
Previous Positions at Alkermes
Before becoming Lead Process Engineer I, Anthony Moffa served in progressive roles at Alkermes. From 2018 to 2022, he worked as Process Development Engineer II in Waltham, MA, focusing on refining and optimizing pharmaceutical processes. Prior to this, from 2014 to 2017, he was Process Development Engineer I, where he played a significant role in the initial phases of project development and execution.
Educational Background in Chemical Engineering
Anthony Moffa graduated from Northeastern University with a Bachelor of Science (BS) in Chemical Engineering, completing his studies from 2009 to 2014. His education provided a strong foundation in chemical engineering principles, with practical experience in laboratory and industrial settings, preparing him for a career in the pharmaceutical industry.
Early Career and Co-op Experience
Anthony Moffa's early career includes several co-op and research roles that provided diverse experience in the pharmaceutical industry. In 2014, he worked briefly as a Research Associate in Pharmaceutical Development at Pulmatrix Inc. In 2013, he focused on drug delivery formulations and development during a five-month co-op at Ocular Therapeutix, Inc. Additionally, he engaged in cellular and metabolic engineering research at Northeastern University from 2013 to 2014.
Specialized Skills in Process Development
Throughout his career, Anthony Moffa has built extensive expertise in process development and technical operations within the pharmaceutical industry. His roles at Acceleron Pharma and Selecta Biosciences were particularly influential, where he gained hands-on experience in cell culture process development and focused on innovative biotechnological processes, respectively. These positions have equipped him with a comprehensive skill set tailored to efficient pharmaceutical process management.